Wells Fargo Maintains Overweight on Johnson & Johnson, Lowers Price Target to $275

Benzinga · 1d ago
Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and lowers the price target from $282 to $275.